Perspectives in Transfusion Medicine and Cellular Therapies

por Schlenke, Peter
Publicado em 2014

Pathogen Inactivation Technologies for Cellular Blood Components: an Update

por Schlenke, Peter
Publicado em 2014

Novel Aspects in Manufacture, Storage, and Transfusion of Blood Components

por Schlenke, Peter
Publicado no Transfus Med Hemother (2019)

As for the Past, as for 2010

por Schlenke, Peter, Sibrowski, Walter
Publicado em 2010

Cross-Sectional Guidelines: Cutting Edge in Scientific Evidence and Practical Guidance

por Schlenke, Peter, Sibrowski, Walter
Publicado em 2009

Patient Blood Management: Clinical Hemotherapy and Hemostasis Management in Perioperative Settings

por Görlinger, Klaus, Schlenke, Peter
Publicado em 2012

Massive Bleeding and Massive Transfusion

por Meißner, Andreas, Schlenke, Peter
Publicado em 2012

Hematopoietic Growth Factors in Transfusion Medicine and Cellular Therapy – Part I

por Schlenke, Peter, Humpe, Andreas
Publicado em 2013

Hematopoietic Growth Factors in Transfusion Medicine and Cellular Therapy – Part II

por Schlenke, Peter, Humpe, Andreas
Publicado em 2013

Safeguards in Blood Supply: A National and European Challenge

por Frey, Beat M., Schlenke, Peter
Publicado em 2010

Patient Blood Management: It Is Time to Streamline Targeted Therapy Options

por Schlenke, Peter, Spahn, Donat R.
Publicado no Transfus Med Hemother (2015)

Congress of the German Society of Transfusion Medicine and Immunohematology - 50th Anniversary

por Klüter, Harald, Gathof, Birgit, Schlenke, Peter
Publicado no Transfus Med Hemother (2017)

Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects

por Rosskopf, Konrad, Helmberg, Wolfgang, Schlenke, Peter
Publicado no Transfusion (2020)

Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

por Lindner, Ulrich, Kramer, Jan, Rohwedel, Jürgen, Schlenke, Peter
Publicado em 2010

Construction and characterization of stably transfected BHK-21 cells with human-type sialylation characteristic

por Schlenke, Peter, Grabenhorst, Eckart, Nimtz, Manfred, Conradt, Harald S.
Publicado em 1999

Characterization of the novel HLA‐C*14:124 allele by next generation sequencing

por Ulrich, Silvia, Lang, Johanna, Posch, Ursula, Schlenke, Peter
Publicado no HLA (2021)

The Impact of the German Tissue Act on the Manufacturing of Autologous and Allogeneic Stem Cell Preparations

por Schlenke, Peter, Tapernon, Karin, Ahlke, Christoph, Mertens, Alexandra, Sibrowski, Walter
Publicado em 2008

Clinical Perspectives of Mesenchymal Stem Cells

por Kramer, Jan, Dazzi, Francesco, Dominici, Massimo, Schlenke, Peter, Wagner, Wolfgang
Publicado em 2012

Does Offline Beat Inline Treatment: Investigation into Extracorporeal Photopheresis

por Helmberg, Wolfgang, Sipurzynski, Sabine, Groselje-Strehle, Andrea, Greinix, Hildegard, Schlenke, Peter
Publicado no Transfus Med Hemother (2020)

High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial

por Macher, Susanne, Drexler, Camilla, Lindenau, Ines, Sareban, Nazanin, Schlenke, Peter, Amrein, Karin
Publicado no Trials (2016)